welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
APC Germline Mutations in Individuals Being Evaluated for Familial Adenomatous Polyposis: A Review of the Mayo Clinic Experience With 1591 Consecutive Tests
source: The Journal of molecular diagnostics
year: 2013
authors: Kerr S E, Thomas C B, Thibodeau S N, Ferber M J, Halling K C
summary/abstract:Inactivating APC mutations cause familial adenomatous polyposis, classically characterized by hundreds to thousands of adenomatous colorectal polyps and cancer. Historically, 98% of pathogenic alterations in APC are nonsense or frameshift mutations; however, few reported series have used techniques that test for large deletions or duplications. Splice site mutations are only rarely documented. Consecutive cases (n = 1591) submitted for complete APC gene analysis during a 4-year period were reviewed. Testing included mutation screening (Sanger sequencing or conformation sensitive gel electrophoresis and protein truncation testing) with reflex confirmation sequencing. Gene deletion or duplication analysis was performed in 1421 cases by multiplex ligation-dependent probe amplification. Testing yielded 411 pathogenic, 20 likely pathogenic, 15 variant of uncertain significance, 140 likely benign, and 1005 negative reports. Identified were 168 novel variants (103 pathogenic, 5 likely pathogenic, 12 variant of uncertain significance, and 48 likely benign). Of the 431 pathogenic or likely pathogenic mutations, frameshift, nonsense, splice site, and large deletion or duplication mutations represented 43%, 42%, 9%, and 6% of cases, respectively. This is the largest report of clinical APC testing experience with concurrent multiplex ligation-dependent probe amplification. In addition to nonsense and frameshift mutations, large deletions or duplications and canonical splice site mutations are a significant cause of familial adenomatous polyposis. Despite technological advances, broad allelic, locus, and phenotypic heterogeneity continue to pose challenges for genetic testing of patients with colorectal adenomatous polyposis.
organization: Mayo ClinicDOI: 10.1016/j.jmoldx.2012.07.005
read more full text source
expertly curated content related to this topic
-
Mutational Spectrum of APC and Genotype-Phenotype Correlations in Greek FAP PatientsBACKGROUND : Familial adenomatous polypo...
-
MutY, E. Coli, Homolog of; MUTYHA summary of mutY/MYH/MUTYH...
-
Biallelic APC Inactivation was Responsible for Functional Adrenocortical Adenoma in Familial Adenomatous Polyposis w...Familial adenomatous polyposis (FAP) pat...
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomicsBackground: Saliva, blood, tissue, and ...
-
Serrated and Non-Serrated Precursor Lesions of Colorectal CancerAlthough often viewed as a single diseas...
-
Familial Risk-Colorectal Cancer: ESMO Clinical Practice GuidelinesLynch syndrome is the most common heredi...
-
Familial Investigations of Childhood Cancer PredispositionWhile it is well recognized that heredit...